Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases

Date Title
Toggle Summary Stryker increases dividend 11%, declaring a $0.52 per share quarterly dividend
Kalamazoo, Michigan , Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on January 31, 2019 to shareholders of record at the close of business
Toggle Summary Stryker announces pricing of €2.25 billion senior notes offering
Kalamazoo, Michigan , Nov. 27, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it has priced the following notes: (i) €550 million aggregate principal amount of the Company’s 1.125% Notes due 2023 (the “2023 Notes”), (ii) €750 million aggregate principal amount of the Company’s
Toggle Summary Stryker to participate in Evercore ISI HealthCONx Conference
Kalamazoo, Michigan , Nov. 20, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts . Katherine Owen , Vice President, Strategy and Investor Relations, will
Toggle Summary Stryker completes acquisition of K2M
Kalamazoo, Michigan , Nov. 09, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc. , a global leader of complex spine and minimally invasive solutions. "K2M's broad product portfolio and robust pipeline complement Stryker’s
Toggle Summary Stryker reports third quarter 2018 operating results
Reported net sales increased 7.9% to $3.2 billion Organic net sales increased 7.9% Reported operating income margin of 17.8% Adjusted operating income margin (1) expanded 60 bps (40 bps excluding ASC 606 (2) ) to 24.9% Reported EPS increased 36.0% to $1.55 Adjusted EPS (3) increased 11.2% to $1.69
Toggle Summary Stryker completes acquisition of Invuity, Inc.
Kalamazoo, Michigan - October 23, 2018 - Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc.  Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical
Toggle Summary Stryker to host analyst meeting
Kalamazoo, Michigan - October 4, 2018 - Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 8, 2018 , at 2:30 p.m. Eastern Time , in Mahwah, New Jersey.  A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at
Toggle Summary Stryker acquires HyperBranch Medical Technology, Inc.
Kalamazoo, Michigan - October 1, 2018 - Stryker (NYSE:SYK) announced today the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all cash transaction. HyperBranch is dedicated to developing medical devices based on its
Toggle Summary Stryker to host conference call on October 25, 2018
Kalamazoo, Michigan - September 20, 2018 - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 25, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended September 30, 2018 and provide an operational update.
Toggle Summary Stryker announces definitive agreement to acquire Invuity, Inc.
Kalamazoo, Michigan - September 11, 2018 - Stryker (NYSE: SYK) announced today a definitive agreement to acquire all the issued and outstanding shares of common stock of Invuity, Inc. (NASDAQ: IVTY) for $7.40 per share, or a total equity value of approximately $190 million .
Toggle Summary Stryker to participate in Morgan Stanley 16th Annual Global Healthcare Conference
Kalamazoo, Michigan - September 4, 2018 - Stryker (NYSE:SYK) will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday, September 12, 2018 at the Grand Hyatt New York in New York City . Katherine Owen , Vice President, Strategy and Investor Relations, will
Toggle Summary Stryker announces definitive agreement to acquire K2M
Kalamazoo, Michigan - August 30, 2018 - Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of K2M Group Holdings, Inc. (NASDAQ: KTWO) for $27.50 per share, or a total equity value of approximately $1.4 billion .
Toggle Summary Stryker to participate in 2018 Wells Fargo Securities Healthcare Conference
Kalamazoo, Michigan - August 22, 2018 - Stryker (NYSE:SYK) will participate in the 2018 Wells Fargo Securities Healthcare Conference on Thursday, September 6, 2018 at the Westin Copley Place in Boston, Massachusetts . Katherine Owen , Vice President, Strategy and Investor Relations, will represent
Toggle Summary Stryker declares a $0.47 per share quarterly dividend
Kalamazoo, Michigan - August 1, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on October 31, 2018 to shareholders of record at the close of business on September 28, 2018 , representing an increase of
Toggle Summary Stryker reports second quarter 2018 operating results
Reported net sales increased 10.3% to $3.3 billion Organic net sales increased 7.9% Reported operating income margin of 20.2% Adjusted operating income margin (1) expanded 70 bps (50 bps excluding ASC 606 (2) ) to 25.7% Reported EPS increased 15.5% to $1.19 Adjusted EPS (3) increased 15.0% to $1.76
Toggle Summary Stryker announces organizational changes
Kalamazoo, Michigan - July 10, 2018 - Stryker Corporation (NYSE:SYK) announced today that David K. Floyd , Group President, Orthopaedics has notified the Company of his intent to retire on June 30, 2019. Until this date, Mr. Floyd will serve as Group President and Advisor to the CEO and will assist
Toggle Summary Stryker announces definitive agreement to acquire SafeAir AG
Kalamazoo, Michigan - June 25, 2018 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire SafeAir AG , a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions.
Toggle Summary Stryker to host conference call on July 24, 2018
Kalamazoo, Michigan - June 19, 2018 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, July 24, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended June 30, 2018 and provide an operational update.
Toggle Summary Stryker to participate in Bank of America Merrill Lynch 2018 Health Care Conference
Kalamazoo, Michigan - May 4, 2018 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2018 Health Care Conference on Tuesday, May 15, 2018 at the Encore at Wynn Hotel in Las Vegas, Nevada .  Glenn Boehnlein, Vice President and Chief Financial Officer, will
Toggle Summary Stryker declares a $0.47 per share quarterly dividend
Kalamazoo, Michigan - May 2, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on July 31, 2018 to shareholders of record at the close of business on June 29, 2018 , representing an increase of approximately 11%
Toggle Summary Stryker to participate in Deutsche Bank's 43rd Annual Health Care Conference
Kalamazoo, Michigan - May 1, 2018 - Stryker Corporation (NYSE:SYK) will participate in Deutsche Bank's 43 rd Annual Health Care Conference on Tuesday, May 8, 2018 at the Intercontinental Hotel Boston .  Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a
Toggle Summary Stryker reports first quarter 2018 operating results
Reported net sales increased 9.7% to $3.2 billion Organic net sales increased 7.0% despite one less selling day Reported operating income margin of 18.2% Adjusted operating income margin (2) expanded 70 bps (50 bps excluding ASC 606 (1) ) to 25.0% Reported EPS decreased 0.9% to $1.16 Adjusted EPS
Toggle Summary Stryker announces organizational changes: Lonny J. Carpenter to retire
Kalamazoo, Michigan - April 3, 2018 - Stryker Corporation (NYSE:SYK) announced today that after 30 years of distinguished service, Lonny Carpenter , Group President, Global Quality and Business Operations has notified the Company of his intent to retire on March 31, 2019 . Mr.
Toggle Summary Stryker to host conference call on April 26, 2018
Kalamazoo, Michigan - March 22, 2018 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, April 26, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended March 31, 2018 and provide an operational update.
Toggle Summary Stryker announces Annual Meeting of Shareholders
Kalamazoo, Michigan - March 21, 2018 - Stryker Corporation (NYSE:SYK) announced that its 2018 Annual Meeting of Shareholders is scheduled as follows: May 2, 2018 - 2:00 p.m. Eastern Time Radisson Plaza Hotel & Suites at The Kalamazoo Center Kalamazoo, Michigan                 Information about the
Toggle Summary Stryker completes acquisition of Entellus Medical
Kalamazoo, Michigan - February 28, 2018 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Entellus Medical.  Entellus is a high-growth global medical technology company focused on delivering superior patient and physician experiences through
Toggle Summary Stryker Corporation announces pricing of $600 million senior notes offering
Kalamazoo, Michigan - February 26, 2018 - Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $600 million of senior unsecured notes due 2028 (the "Notes").  The Notes will bear interest at 3.650% per year and, unless previously redeemed, will mature on March 7 ,
Toggle Summary Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for eighth consecutive year
Kalamazoo, Michigan - February 15, 2018 - Stryker Corporation (NYSE:SYK) announced today that it has been named one of Fortune's 2018 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States . The list recognizes companies that have exceptional
Toggle Summary Stryker crosses the 95% thresholds in VEXIM and announces its intention to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM
Kalamazoo, Michigan - February 14, 2018 - Stryker Corporation (NYSE:SYK) announced that it has crossed the 95% thresholds in VEXIM and intends to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM , in accordance with French tender offer laws and
Toggle Summary Stryker declares a $0.47 per share quarterly dividend
Kalamazoo, Michigan - February 7, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on April 30, 2018 to shareholders of record at the close of business on March 29, 2018 , representing an increase of
Toggle Summary Stryker reports 2017 results and 2018 outlook
Kalamazoo, Michigan - January 30, 2018 - Stryker Corporation (NYSE:SYK) reported 2017 operating results for the fourth quarter and full year and 2018 outlook: Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% constant currency) Orthopaedics 8.1 % or 6.8 % constant currency
Toggle Summary Stryker provides 2017 preliminary net sales results
Kalamazoo, Michigan - January 9, 2018 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2017 were: Preliminary Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% constant currency) Orthopaedics 8.1 % or 6.8 % constant
Toggle Summary Stryker announces nomination of two new Directors, Sheri S. McCoy and Rajeev Suri
Kalamazoo, Michigan - January 8, 2018 - Stryker Corporation (NYSE:SYK) announced that Sherilyn (Sheri) S. McCoy and Rajeev Suri have been nominated for election to the Company's Board of Directors at Stryker's 2018 Annual Meeting of Shareholders, which is expected to be held on May 2 , 2018.  Their
Toggle Summary Stryker to participate in 36th Annual J.P. Morgan Healthcare Conference
Kalamazoo, Michigan - January 2, 2018 - Stryker Corporation (NYSE:SYK) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at the Westin St. Francis hotel in San Francisco .  Kevin A. Lobo, Chairman and Chief Executive Officer, will represent the
Toggle Summary Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
Kalamazoo, Michigan - December 12, 2017 - Stryker Corporation (NYSE:SYK) announced today that after 44 years of distinguished service, Mr. Howard E. Cox, Jr. has notified the Company that he will not stand for re-election at Stryker's 2018 Annual Meeting of Shareholders, which is expected to be
Toggle Summary Stryker announces the success of the simplified tender offer for outstanding shares of VEXIM
Kalamazoo, Michigan - December 11, 2017 - Stryker Corporation (NYSE:SYK) announced that the simplified public tender offer for the shares and BSAAR warrants of VEXIM , a French medical device company listed on the Euronext Growth stock exchange in France , has closed.  VEXIM , headquartered in
Toggle Summary Stryker announces definitive agreement to acquire Entellus
Kalamazoo, Michigan – December 7, 2017 – Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an equity value of approximately $662 million. Entellus is a high-growth global medical technology company
Toggle Summary Stryker increases dividend 11%, declaring a $0.47 per share quarterly dividend
Kalamazoo, Michigan – December 6, 2017 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record at the close of business on December 29, 2017, representing an increase of
Toggle Summary Stryker reports third quarter 2017 results
Kalamazoo, Michigan - October 26, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2017: Third Quarter Highlights Net sales grew 6.1% to $3.0 billion (5.8% constant currency) Orthopaedics 5.1 % or 4.8 % constant currency MedSurg 6.7 % or 6.2 % constant
Toggle Summary Stryker to acquire VEXIM
Kalamazoo, Michigan – October 24, 2017 – Stryker Corporation (NYSE:SYK) announced that it has acquired control of VEXIM, a French medical device company listed on the Euronext Growth stock exchange in France. VEXIM, headquartered in Balma, France, specializes in the development and sale of
Toggle Summary Stryker to host conference call on October 26, 2017
Kalamazoo, Michigan – September 21, 2017 – Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 26, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2017 and provide an operational update.
Toggle Summary Stryker to participate in Morgan Stanley 15th Annual Global Healthcare Conference
Kalamazoo, Michigan – September 6, 2017 – Stryker Corporation (NYSE:SYK) will participate in the Morgan Stanley 15th Annual Global Healthcare Conference on Tuesday, September 12, 2017 at the Grand Hyatt Hotel in New York, New York.  Kevin Lobo, Chairman and Chief Executive Officer, will
Toggle Summary Stryker completes acquisition of NOVADAQ Technologies Inc.
Kalamazoo, Michigan – September 1, 2017 – Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of NOVADAQ Technologies Inc.  NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood
Toggle Summary Stryker provides an update regarding Sage warning letter and revised financial guidance
Kalamazoo, Michigan – August 23, 2017 – Stryker Corporation (NYSE: SYK) announced today that the company has informed the U.S. Food and Drug Administration (FDA) of a voluntary product recall involving specific lots of Oral Care products sold through the company’s Sage Products business unit
Toggle Summary Stryker announces election of new Director, Mary K. Brainerd
Kalamazoo, Michigan - August 2, 2017 - Stryker Corporation (NYSE:SYK) announced the addition of a new member to its Board of Directors with the election of Mary K. Brainerd as a Director, effective August 1, 2017. Ms. Brainerd was most recently President and Chief Executive Officer of
Toggle Summary Stryker declares a $0.425 per share quarterly dividend
Kalamazoo, Michigan - August 2, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on October 31, 2017 to shareholders of record at the close of business on September 29, 2017, representing an increase of 12%
Toggle Summary Stryker reports second quarter 2017 results
Kalamazoo, Michigan - July 27, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2017: Second Quarter Highlights Net sales grew 6.1% to $3.0 billion (6.9% constant currency) Orthopaedics 5.5 % or 6.5% constant currency MedSurg 6.2 % or 6.8% constant currency
Toggle Summary Stryker to host conference call on July 27, 2017
Kalamazoo, Michigan - June 22, 2017 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 27, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2017 and provide an operational update.
Toggle Summary Stryker announces definitive agreement to acquire NOVADAQ Technologies Inc.
Toggle Summary Stryker to participate in Goldman Sachs 38th Annual Global Healthcare Conference
Toggle Summary Stryker Orthopaedics 2016 Settlement Program reaches milestone
Toggle Summary Stryker to participate in Bank of America Merrill Lynch 2017 Health Care Conference
Toggle Summary Stryker declares a $0.425 per share quarterly dividend
Toggle Summary Stryker reports first quarter 2017 results
Toggle Summary Stryker to host conference call on April 25, 2017
Toggle Summary Stryker announces Annual Meeting of Shareholders
Toggle Summary Stryker enabling surgeons to have a more predictable surgical experience with launch of Mako robotic-arm assisted total knee application
Toggle Summary Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year
Toggle Summary Stryker to participate in Cowen & Company 37th Annual Health Care Conference
Toggle Summary Stryker declares a $0.425 per share quarterly dividend
Toggle Summary Stryker reports 2016 results and 2017 outlook
Toggle Summary Stryker provides 2016 preliminary net sales results
Toggle Summary Stryker to participate in 35th Annual J.P. Morgan Healthcare Conference
Toggle Summary Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems
Toggle Summary Stryker increases 2017 annual dividend by 12% and declares a $0.425 per share quarterly dividend
Toggle Summary Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India
Toggle Summary Stryker to participate in Stifel 2016 Healthcare Conference
Toggle Summary Stryker reports third quarter 2016 results
Toggle Summary Stryker to host analyst meeting
Toggle Summary Stryker to host conference call on October 27, 2016
Toggle Summary Stryker to participate in Morgan Stanley Global Healthcare Conference
Toggle Summary Stryker to participate in 11th Annual Wells Fargo Securities Healthcare Conference
Toggle Summary Stryker declares a $0.38 per share quarterly dividend
Toggle Summary Stryker reports second quarter 2016 results
Toggle Summary Stryker to host conference call on July 21, 2016
Toggle Summary Stryker to participate in Goldman Sachs 37th Annual Global Healthcare Conference
Toggle Summary Stryker to participate in UBS 2016 Global Healthcare Conference
Toggle Summary Stryker to participate in Bank of America Merrill Lynch 2016 Health Care Conference
Toggle Summary Stryker acquires Stanmore Implants Worldwide Limited
Toggle Summary Stryker declares a $0.38 per share quarterly dividend
Toggle Summary Stryker announces completion of the acquisition of vertebral compression fracture portfolio from BD
Toggle Summary Stryker reports first quarter 2016 results
Toggle Summary Stryker completes acquisition of Physio-Control International, Inc.
Toggle Summary Stryker completes the acquisition of Synergetics USA, Inc.'s Neuro Portfolio
Toggle Summary Stryker completes acquisition of Sage Products, LLC
Toggle Summary Stryker announces Annual Meeting of Shareholders
Toggle Summary Stryker to host conference call on April 20, 2016
Toggle Summary Stryker Corporation Announces Pricing of $3.5 Billion Senior Notes Offering
Toggle Summary Stryker Corporation named one of Fortune magazine's "100 Best Companies to Work For" for sixth consecutive year
Toggle Summary Stryker to Participate in Cowen & Company 36th Annual Health Care Conference
Toggle Summary Stryker to Participate in Canaccord Genuity 2016 Musculoskeletal Conference
Toggle Summary Stryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion
Toggle Summary Stryker Announces Definitive Agreement to Acquire Synergetics USA, Inc.'s Neuro Portfolio
Toggle Summary Stryker Declares a $0.38 per Share Quarterly Dividend
Toggle Summary Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
Toggle Summary Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
Toggle Summary Stryker Reports 2015 Results and 2016 Outlook
Toggle Summary Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance
Toggle Summary Stryker to Participate in 34th Annual J.P. Morgan Healthcare Conference
Toggle Summary Stryker Declares a $0.38 per Share Quarterly Dividend
Toggle Summary Stryker Corporation Announces Pricing of $750 Million Senior Notes Offering
Toggle Summary Stryker Reports Third Quarter 2015 Results
Toggle Summary Stryker to Host Conference Call on October 22, 2015
Toggle Summary Stryker to Participate in 2015 Morgan Stanley Global Healthcare Conference
Toggle Summary Stryker Completes Acquisition of Muka Metal, A.S.
Toggle Summary Stryker to Participate in 2015 Wells Fargo Securities Healthcare Conference
Toggle Summary Stryker Receives FDA Clearance For Mako Total Knee Application
Toggle Summary Stryker to Participate in Canaccord Genuity 35th Annual Growth Conference
Toggle Summary Stryker Declares a $0.345 per Share Quarterly Dividend
Toggle Summary Stryker Reports Second Quarter 2015 Results
Toggle Summary Stryker Announces Definitive Agreement to Acquire Muka Metal, A.S.
Toggle Summary Stryker to Host Conference Call on July 23, 2015
Toggle Summary Stryker Orthopaedics Settlement Program Reaches Milestone - - 95% of Registered Eligible U.S. Patients Enrolled in Program
Toggle Summary Stryker to Participate in Jefferies 2015 Healthcare Conference
Toggle Summary Stryker to Participate in UBS Global Healthcare Conference
Toggle Summary Stryker to Participate in Bank of America Merrill Lynch 2015 Health Care Conference
Toggle Summary Stryker Declares a $0.345 per Share Quarterly Dividend
Toggle Summary Stryker Reports First Quarter 2015 Results
Toggle Summary Stryker Announces Annual Meeting of Shareholders
Toggle Summary Stryker to Host Conference Call on April 21, 2015
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Corporation Named One of Fortune Magazine's "100 Best Companies to Work For®" For 5th Consecutive Year
Toggle Summary Stryker Announces New $2 Billion Share Repurchase Authorization
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Declares a 13% Increase in Quarterly Dividend
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Reports 2014 Results and 2015 Outlook
Toggle Summary Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Acquires the Assets of CHG Hospital Beds, Inc.
Toggle Summary Stryker Resolves Government Investigation of OtisMed Matter
Toggle Summary Stryker Declares a 13% Increase in Quarterly Dividend
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Orthopaedics Announces Settlement Agreement To Compensate Eligible U.S. Patients Who Had Surgery To Replace Their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems
Toggle Summary Stryker Reports Third Quarter 2014 Results and 2014 Outlook
Toggle Summary Stryker to Host Conference Call on October 16, 2014
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Completes Acquisition of North American Assets of Small Bone Innovations, Inc.
Toggle Summary Stryker Announces Appointment of Kevin A. Lobo as Chairman of the Board of Directors
Toggle Summary Stryker Declares a $0.305 Quarterly Dividend
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Reports Second Quarter 2014 Results and 2014 Outlook
Toggle Summary Stryker Announces Definitive Agreement to Acquire Assets of Small Bone Innovations, Inc.
Toggle Summary Stryker to Host Conference Call on July 17, 2014
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Corporation Announces Pricing of $1.0 Billion Senior Notes Offering
Toggle Summary Stryker Reports First Quarter 2014 Results and 2014 Outlook
Toggle Summary Stryker Declares a $0.305 Quarterly Dividend
Toggle Summary Stryker Completes Acquisition of Berchtold Holding AG
Toggle Summary Stryker Announces Legal Function Leadership Change
Toggle Summary Stryker to Host Conference Call on April 23, 2014
Toggle Summary Stryker Completes Acquisition of Patient Safety Technologies, Inc.
Toggle Summary Stryker Announces Annual Meeting of Shareholders
Toggle Summary Stryker Completes Acquisition of Pivot Medical, Inc.
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Definitive Agreement to Acquire Pivot Medical, Inc.
Toggle Summary Stryker Announces Definitive Agreement to Acquire Berchtold Holding, AG
Toggle Summary Stryker Declares a 15% Increase in Quarterly Dividend
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Reports Fourth Quarter and Full Year 2013 Results and 2014 Outlook
Toggle Summary Stryker Corporation Named One of Fortune Magazine's "100 Best Companies to Work For"
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Definitive Agreement to Acquire Patient Safety Technologies, Inc. for $120 Million
Toggle Summary Stryker Receives FDA Clearance for Waste Management System
Toggle Summary Stryker Completes Acquisition of MAKO Surgical Corp.
Toggle Summary Stryker to Provide Fourth Quarter 2013 Results and 2014 Outlook on January 22, 2014
Toggle Summary Stryker Declares a 15% Increase in Quarterly Dividend
Toggle Summary Stryker Announces Election of New Director, Andrew K. Silvernail
Toggle Summary Stryker Reports Third Quarter 2013 Results
Toggle Summary Stryker Announces Definitive Agreement to Acquire MAKO Surgical Corp. for $1.65 Billion
Toggle Summary Stryker to Host Conference Call on October 17, 2013
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Declares a $0.265 Per Share Quarterly Dividend
Toggle Summary Stryker Reports Second Quarter 2013 Results
Toggle Summary Stryker to Host Conference Call on July 18, 2013
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Declares a $0.265 Per Share Quarterly Dividend
Toggle Summary Stryker Reports First Quarter 2013 Results
Toggle Summary FDA Classifies Voluntary ShapeMatch® Cutting Guides Recall as Class I Recall
Toggle Summary Stryker Announces Appointment of William Jellison to the Position of Vice President, Chief Financial Officer
Toggle Summary Stryker to Host Conference Call on April 24, 2013
Toggle Summary Stryker Announces Annual Meeting of Shareholders
Toggle Summary Stryker Corporation Announces Pricing of $1.0 Billion Senior Notes Offering
Toggle Summary Stryker Receives FDA Warning Letter
Toggle Summary Stryker Announces $250 Million Accelerated Share Repurchase Program
Toggle Summary Stryker Completes Acquisition of Trauson Holdings Company Limited
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Correction of Dividend Record Date
Toggle Summary Stryker Declares a $0.265 per Share Quarterly Dividend
Toggle Summary Stryker Reports Fourth Quarter and Full Year 2012 Results
Toggle Summary Stryker Announces Definitive Offer to Acquire Trauson Holdings Company Limited
Toggle Summary Stryker Corporation Named One of Fortune Magazine's "100 Best Companies to Work For"
Toggle Summary Stryker Provides Preliminary 2012 Results and Updates 2013 Outlook
Toggle Summary Stryker Announces Appointment of Scott Bruder, MD, PhD to the Position of Vice President, Chief Medical and Scientific Officer
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Declares a 25% Increase in Quarterly Dividend and Announces Increase in Its Share Repurchase Authorization to $1 Billion
Toggle Summary Stryker Announces Changes to Executive Leadership
Toggle Summary Stryker Completes Acquisition of Privately-Held Surpass Medical, Ltd.
Toggle Summary Stryker Reports Third Quarter 2012 Results
Toggle Summary Stryker Announces Definitive Agreement to Acquire Privately-Held Surpass Medical, Ltd. for $135 Million
Toggle Summary Stryker Names Kevin A. Lobo as President and Chief Executive Officer
Toggle Summary Stryker to Host Conference Call on October 17, 2012
Toggle Summary Stryker Declares a $0.2125 per Share Quarterly Dividend
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Reports Second Quarter 2012 Results
Toggle Summary Stryker Declares a $0.2125 per Share Quarterly Dividend
Toggle Summary Stryker to Host Conference Call on July 18, 2012
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Reports First Quarter 2012 Results
Toggle Summary Stryker Announces Annual Meeting of Shareholders
Toggle Summary Stryker to Host Conference Call on April 17, 2012
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Declares a $0.2125 Per Share Quarterly Dividend
Toggle Summary Stephen P. MacMillan Resigns as Chairman, President and CEO of Stryker Corporation
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Reports Fourth Quarter and Full Year 2011 Results
Toggle Summary Stryker Corporation Named One of Fortune Magazine's "100 Best Companies to Work For"
Toggle Summary Stryker Reaches Settlement with the U.S. Attorney's Office
Toggle Summary Stryker Increases Expected 2011 Results and Provides 2012 Outlook
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Additional $500 Million Share Repurchase Program and Declares 18% Increase in Quarterly Dividend
Toggle Summary Stryker Announces Completion of TREVO 2 Trial Enrollment
Toggle Summary Stryker Announces Actions to Drive Over $100 Million In Annual Productivity Gains
Toggle Summary Stryker Reports Third Quarter 2011 Results
Toggle Summary Stryker Completes Acquisition of Privately-Held Concentric Medical, Inc.
Toggle Summary Stryker Corporation Announces Pricing of Senior Notes
Toggle Summary Stryker to Host Conference Call on October 19, 2011
Toggle Summary Stryker Announces Definitive Agreement to Acquire Privately Held Concentric Medical, Inc. for $135 Million
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Declares a $0.18 Per Share Quarterly Dividend
Toggle Summary Stryker Appoints Ramesh Subrahmanian to Group President, International
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Reports 16% Sales Growth, 12.5% Adjusted Diluted Net Earnings Per Share Growth For Quarter Ended June 30, 2011
Toggle Summary Stryker Completes Acquisition of Privately-Held Memometal Technologies S.A.
Toggle Summary Stryker Completes Acquisition of Orthovita, Inc.
Toggle Summary Stryker Announces Successful Completion Of Tender Offer For Orthovita, Inc. With Over 87.6% of Shares Tendered
Toggle Summary Stryker to Host Conference Call on July 19, 2011
Toggle Summary Stryker Declares a $0.18 Per Share Quarterly Dividend
Toggle Summary Stryker Announces Definitive Agreement to Acquire Privately-Held Memometal Technologies S.A. for $162 Million
Toggle Summary Stryker Appoints Kevin Lobo to Group President, Orthopaedics
Toggle Summary Stryker Commences Tender Offer for Acquisition of Orthovita, Inc.
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Receives FDA 510(K) Clearance for Shapematch® Cutting Guides
Toggle Summary Stryker Announces Definitive Agreement to Acquire Orthovita, Inc. for $3.85 Per Share in Cash
Toggle Summary Stryker Announces Kevin Lobo to Head New Neurotechnology and Spine Group
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Reports 12% Sales Growth, 10% Adjusted Net Earnings Growth for Quarter Ended March 31, 2011
Toggle Summary Stryker Announces Annual Shareholder Meeting
Toggle Summary Stryker to Host Conference Call on April 19, 2011
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Declares a $0.18 Per Share Quarterly Dividend
Toggle Summary Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
Toggle Summary Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
Toggle Summary Stryker Corporation Named One of FORTUNE Magazine's '100 Best Companies to Work For'
Toggle Summary Stryker Increases Expected 2010 Results and Provides 2011 Outlook
Toggle Summary Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Election of New Director
Toggle Summary Stryker Announces Additional $500 Million Share Repurchase Program and Declares a 20% Increase in Quarterly Dividend
Toggle Summary Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Acquisition of Privately-Held Porex Surgical
Toggle Summary Stryker Announces Definitive Agreement to Acquire the Neurovascular Division of Boston Scientific for $1.5 Billion
Toggle Summary Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010
Toggle Summary Stryker Declares a $0.15 Per Share Quarterly Dividend
Toggle Summary Stryker to Host Conference Call on October 19, 2010
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Plans to Acquire Privately Held Gaymar Industries for $150 Million
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Reports 8% Sales Growth, 10% Net Earnings Growth for Quarter Ended June 30, 2010
Toggle Summary Stryker to Host Conference Call on July 20, 2010
Toggle Summary Stryker Announces Election of New Director
Toggle Summary Stryker Declares a $0.15 Per Share Quarterly Dividend
Toggle Summary Stryker Facilities Earn LEED(R) Certifications
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Resolution of Two FDA Warning Letters
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Reports 12% Sales Growth, 14% Net Earnings Growth for Quarter Ended March 31, 2010
Toggle Summary Stryker Announces Annual Shareholder Meeting
Toggle Summary Stryker Announces Resolution of FDA Warning Letter Related to Its Mahwah, New Jersey Manufacturing Facility
Toggle Summary Stryker to Host Conference Call on April 20, 2010
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Declares a $0.15 Per Share Quarterly Dividend
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Reports 7% Sales Growth, 10% Net Earnings Growth for Quarter Ended December 31, 2009
Toggle Summary Stryker Corporation Announces Pricing of Senior Notes
Toggle Summary Stryker Updates Expected 2009 Results and Provides 2010 Outlook
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Completes Acquisition of Ascent Healthcare Solutions
Toggle Summary Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend
Toggle Summary Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions
Toggle Summary Stryker Announces Agreements To Acquire Assets
Toggle Summary Stryker Announces Change in Chairman of the Board of Directors
Toggle Summary Stryker Modifies Its Dividend Policy and Declares Transition Dividend
Toggle Summary Stryker Statement in Response to the Indictment of Its Biotech Division
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2009
Toggle Summary Stryker To Host Conference Call on October 20, 2009
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Organizational Changes
Toggle Summary Stryker Announces Election of New Director
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2009
Toggle Summary Stryker to Host Conference Call on July 21, 2009
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Election of New Director
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2009
Toggle Summary Stryker to Host Conference Call on April 20, 2009
Toggle Summary Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Operating Results for Quarter Ended December 31, 2008
Toggle Summary Stryker Updates Expected 2008 Results and Provides 2009 Outlook
Toggle Summary Stryker To Present at Investor Conference
Toggle Summary Stryker Reduces 2008 Guidance
Toggle Summary Stryker Increases Annual Dividend by Over 20%
Toggle Summary Stryker Announces Organizational and Leadership Changes
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker Announces Additional Share Repurchase Authorization
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2008
Toggle Summary Stryker to Host Conference Call on October 16, 2008
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker To Present at Investor Conference
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2008
Toggle Summary Stryker To Host Conference Call On July 17, 2008
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker's Biotech Division Receives FDA Warning Letter
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2008
Toggle Summary Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
Toggle Summary Stryker to Host Conference Call on April 17, 2008
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Share Repurchase Program
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Host Analyst Meeting
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2007
Toggle Summary Stryker Issues Statement Regarding FDA Warning Letter
Toggle Summary Stryker to Host Conference Call on January 23, 2008
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Increases Annual Dividend by 50%
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2007
Toggle Summary Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
Toggle Summary Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker To Host Conference Call on October 17, 2007
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2007
Toggle Summary FDA Approval Allows Stryker to Market Hip Resurfacing System In Third Quarter of 2007
Toggle Summary Stryker Corporation Recipient of the Gallup Great Workplace Award 2007
Toggle Summary Stryker to Host Conference Call on July 19, 2007
Toggle Summary Stryker Completes Sale of Physiotherapy Associates to Water Street Healthcare Partners for Approximately $150 Million
Toggle Summary Stryker To Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2007
Toggle Summary Stryker to Host Conference Call on April 18, 2007
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces New Corporate Officer Appointment
Toggle Summary Stryker To Present at Investor Conference
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2006
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Host Analyst Meeting During the American Academy of Orthopaedic Surgeons
Toggle Summary Stryker to Host Conference Call on January 25, 2007
Toggle Summary Stryker Doubles Year-End Cash Dividend to Twenty-Two Cents Per Share
Toggle Summary Stryker to Present at Investor Conference
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2006
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Host Conference Call on October 17, 2006
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker(R) Receives FDA Clearance for LFIT(TM) Anatomic Femoral Heads with X3(R) Liners
Toggle Summary Stryker Announces Election of Additional Director
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2006
Toggle Summary Stryker Submits Application to FDA For Spinal Indication For OP-1 Putty
Toggle Summary Stryker Receives Subpoena From Department of Justice
Toggle Summary Stryker to Host Conference Call on July 20, 2006
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Corporate Officer Appointments
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results For Quarter Ended March 31, 2006
Toggle Summary Stryker to Host Conference Call on April 20, 2006
Toggle Summary Stryker Announces Acquisition of Sightline Technologies Ltd.
Toggle Summary Stryker Markets First Total Knee Replacement Designed With Women In Mind
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2005
Toggle Summary Stryker Corporation to Host Analyst Meeting During the American Academy of Orthopaedic Surgeons
Toggle Summary Stryker Orthopaedics Selects NetRegulus NetRM Study Solutions
Toggle Summary Stryker To Present At Investor Conferences
Toggle Summary Stryker To Host Conference Call On January 26, 2006
Toggle Summary Stryker Announces Acquisition of PlasmaSol Corporation and Completion of Cash Repatriation
Toggle Summary Stryker Announces Eleven Cents Per Share Year-End Cash Dividend, a 22% Increase
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker To Present At Investor Conference
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2005
Toggle Summary Stryker Corporation to Host Conference Call on October 18, 2005
Toggle Summary Stryker Announces Plan to Repatriate Foreign Earnings Under the Provisions of the American Jobs Creation Act
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Announces Exclusive Distribution Agreement To Enter Hip Resurfacing Market
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2005
Toggle Summary Stryker Corporation to Host Conference Call on July 19, 2005
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker to Present at Investor Conferences
Toggle Summary Stryker Operating Results For Quarter Ended March 31, 2005
Toggle Summary Stryker Announces Receipt of Subpoena Related to Orthopaedic Service Agreements
Toggle Summary Stryker Corporation to Host Conference Call on April 19, 2005
Toggle Summary Stryker Announces Acquisition of eTrauma
Toggle Summary Stryker Announces Management Changes
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2004
Toggle Summary Stryker Corporation to Host Analyst Meeting During the American Academy of Orthopaedic Surgeons
Toggle Summary Stryker Announces Appointment of Stephen P. MacMillan as President and Chief Executive Officer; John W. Brown Remains Chairman of the Board
Toggle Summary Stryker Announces Year-End Cash Dividend
Toggle Summary Stryker Corporation to Host Conference Call on January 26, 2005
Toggle Summary Stryker Operating Results For Quarter Ended September 30, 2004
Toggle Summary Stryker Corporation to Host Conference Call on October 14, 2004
Toggle Summary Stryker Announces Completion of SpineCore, Inc. Acquisition
Toggle Summary Stryker Announces Management Changes
Toggle Summary Stryker Announces Acquisition of SpineCore, Inc.
Toggle Summary Stryker Operating Results For Quarter Ended June 30, 2004
Toggle Summary Stryker Corporation to Host Conference Call on July 15, 2004
Toggle Summary Stryker Corporation Announces Two-for-One Stock Split
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2004
Toggle Summary Stryker Receives Humanitarian Device Exemption for Use of OP-1 in Revision Spine Surgery
Toggle Summary Stryker Announces the Appointment of Mark A. Philip as President of Stryker Biotech
Toggle Summary Stryker Corporation to Host Conference Call on April 15, 2004
Toggle Summary Stryker Corporation Results for Quarter and Year Ended December 31, 2003
Toggle Summary Stryker Corporation to Host Analyst Meeting During the American Academy of Orthopaedic Surgeons
Toggle Summary Stryker Announces Receipt of Subpoena Related to its Physiotherapy Associates Business
Toggle Summary Stryker Corporation to Host Conference Call on January 29, 2004
Toggle Summary Stryker Announces MedSurg Production Facility Expansions
Toggle Summary Stryker Announces Year-End Cash Dividend
Toggle Summary Stryker Corporation Results for Quarter and Nine Months Ended September 30, 2003
Toggle Summary Stryker Corporation Announces Management Changes
Toggle Summary Stryker Launches Patient Education Campaign With Golf Legend And Hip Replacement Recipient Jack Nicklaus
Toggle Summary Stryker Corporation to Host Conference Call on October 16, 2003
Toggle Summary Stryker Corporation Announces Management Changes
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2003
Toggle Summary Stryker Corporation to Host Conference Call on July 15, 2003
Toggle Summary Stryker Howmedica Osteonics Receives FDA Clearance For Simplex(TM) P With Tobramycin Antibiotic Bone Cement
Toggle Summary Stryker Corporation Appoints Stephen P. MacMillan As President and Chief Operating Officer
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2003
Toggle Summary Stryker Corporation to Host Conference Call on April 16, 2003
Toggle Summary Stryker Howmedica Osteonics Receives FDA Approval Of Ceramic Insert for Hip Replacements
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2002
Toggle Summary Stryker Howmedica Osteonics Launches Online Joint Replacement Resource Center
Toggle Summary Stryker Corporation to Host Conference Call on January 27, 2003
Toggle Summary Stryker Corporation to Hold Analyst Meeting During the American Academy of Orthopaedic Surgeons
Toggle Summary Stryker Announces Year-End Cash Dividend
Toggle Summary Stryker Corporation Announces Management Changes
Toggle Summary Stryker Operating Results for Quarter and Nine Months Ended September 30, 2002
Toggle Summary Stryker Corporation to Host Conference Call on October 16, 2002
Toggle Summary Stryker Announces OP-1 Royalty Agreement
Toggle Summary Stryker Announces Management Appointments
Toggle Summary Stryker to Close Rutherford, New Jersey Manufacturing Facility
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2002
Toggle Summary Stryker Announces Completion of Surgical Dynamics Spinal Business Acquisition
Toggle Summary Stryker Corporation to Host Conference Call on July 16, 2002
Toggle Summary Stryker May Close Rutherford, New Jersey Manufacturing Facility
Toggle Summary Stryker to Acquire Surgical Dynamics Spinal Business for $135 Million in Cash
Toggle Summary Stryker Howmedica Osteonics to Begin Clinical Evaluation On Minimally Invasive Total Knee Project
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2002
Toggle Summary Stryker Corporation to Host Conference Call on April 17, 2002
Toggle Summary Stryker CEO Recovering From Surgery
Toggle Summary Stryker Receives Canadian Approval for OP-1
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2001
Toggle Summary Stryker Corporation to Hold Analyst Meeting During the American Academy of Orthopaedic Surgeons
Toggle Summary Stryker Corporation to Host Conference Call on January 28, 2002
Toggle Summary Stryker Announces $1 Billion Credit Facility
Toggle Summary Stryker Announces Year-End Cash Dividend
Toggle Summary Stryker Announces Management Changes
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2001
Toggle Summary Stryker Receives Humanitarian Device Exemption For OP-1; Stryker's Patented Bone Morphogenetic Protein (BMP) Is the First Approved in the U.S.
Toggle Summary Stryker Announces Management Changes
Toggle Summary Stryker Corporation to Host Conference Call on October 17, 2001
Toggle Summary Stryker Announces Management Changes
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2001
Toggle Summary Stryker Corporation to Host Conference Call on July 17, 2001
Toggle Summary Stryker Reports OP-1 Marketing Authorization in Europe
Toggle Summary Stryker Reports OP-1 Registration in Australia
Toggle Summary Stryker Operating Results For Quarter Ended March 31, 2001
Toggle Summary Stryker Corporation to Host Conference Call on April 18, 2001
Toggle Summary Stryker Reports OP-1 Receives Positive Opinion From Australian ADEC
Toggle Summary Stryker Corporation to Hold Analyst Meeting During The American Academy of Orthopaedic Surgeons
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 2000
Toggle Summary Stryker Reports OP-1 PMA Receives Not-Approvable Letter From FDA
Toggle Summary Stryker Corporation to Host Conference Call on January 29, 2001
Toggle Summary Stryker Reports OP-1 Receives Positive Opinion From European CPMP
Toggle Summary Stryker Announces Year-End Cash Dividend
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 2000
Toggle Summary Stryker Corporation to Host Conference Call on October 17, 2000
Toggle Summary Stryker Corporation Completes Acquisition of Image Guided Technologies, Inc.
Toggle Summary Stryker Operating Results for Quarter Ended June 30, 2000
Toggle Summary Stryker Agrees to Acquire Image Guided Technologies
Toggle Summary Stryker Announces Two-For-One Stock Split
Toggle Summary Stryker Operating Results for Quarter Ended March 31, 2000
Toggle Summary Stryker Announces Management Changes
Toggle Summary Stryker Operating Results for Quarter and Year Ended December 31, 1999
Toggle Summary Stryker Announces Year-End Cash Dividend
Toggle Summary Stryker Operating Results for Quarter Ended September 30, 1999
Toggle Summary Stryker Announces Management Changes
Investor Contacts
Katherine A. Owen
Vice President, Strategy & Investor Relations
Stryker
2825 Airview Boulevard
Kalamazoo, MI 49002
269-385-2600